Beta Agonist Nebulization in Non Invasively Ventilated COPD Patients: Safety, and Therapeutic Efficacy Range.

NCT01958814 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

43

Enrollment

OTHER

Sponsor class

Conditions

Chronic Respiratory Failure

Interventions

DRUG: Salbutamol
DRUG: Placebo

Sponsor

University Hospital, Tours